Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SGP

+ Watchlist+ Portfolio

SpyGlass Pharma, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$31.44
52-Week Range
$17.06 – $39.92
Market Cap
$993.14M
P/E (TTM)
—
EPS (TTM)
-2.70
Dividend Yield
0.00%
Advanced Metrics
Price/Book
4.72
PEG Ratio
—
Return on Equity
-43.01%
Return on Assets
-27.33%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
15.24
Debt/Equity
0.01
Total Debt
$1.61M
Free Cash Flow
$-37.95M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$778.99M

Market Snapshot

About

SpyGlass Pharma, Inc. is a biopharmaceutical company developing treatments for gastrointestinal diseases. The company focuses on novel therapeutic candidates for conditions affecting the digestive system. SpyGlass is working to advance its pipeline through clinical development.